Categories: DNANews

Sequentify Announces Research Grants for High-Throughput Genomic Studies

REHOVOT, Israel, April 17, 2025 /PRNewswire/ — Sequentify is offering research grants to accelerate high-impact genomic studies through its uniquely fast, easy-to-use, and scalable targeted library preparation technology. Designed to enable the widespread adoption of high-throughput genomic testing, Sequentify’s protocol is ideal for large-scale programs conducting targeted sequencing at the population or cohort level.

We invite proposals from research groups conducting genomic DNA studies using human-derived samples, regardless of research field. Eligible areas include, but are not limited to: oncology, rare disease, reproductive health, infectious disease, population screening, and public health.

 To qualify, proposed studies must:

  • Involve 5,000 human samples or more
  • Require Sequentify’s off-the-shelf or customized panels (up to 10,000 genomic targets)

Selected applicants will receive:

  • Reagents for up to 10,000 samples
  • Access to Sequentify’s end-to-end analysis software

Submission Guidelines: In up to 250 words, describe how this grant would enhance your research and contribute to your scientific field.

Application period: April 5 – June 20, 2025

Submit applications to: hello@sequentify.com 

If you have questions about the grant or your project’s eligibility, feel free to reach out to us at the same address—we’d be happy to help.

About Sequentify:

Founded in 2021 as a Weizmann Institute spinoff, Sequentify enables decentralized, population-wide genomic sequencing by providing laboratories with the easiest and quickest solutions available. Their technology facilitates the scaling-up of genomic testing by directly addressing the current pain points in the industry, through sample-prep and software solutions. The company offers panels for oncology and screening applications, and infectious diseases, with a focus on the clinical market. Sequentify is based in Rehovot, Israel. For more information about the company, visit https://www.sequentify.com/.

Media Contact:
Avigayil Simpson
avigayil@sequentify.com

Logo: https://healthtechnologynet.com/wp-content/uploads/2025/04/SEQUENTIFY_Logo.jpg

 

View original content:https://www.prnewswire.com/news-releases/sequentify-announces-research-grants-for-high-throughput-genomic-studies-302431271.html

SOURCE Sequentify

Staff

Recent Posts

Medtronic announces filing of IPO registration statement for Diabetes business, MiniMed

GALWAY, Ireland, Dec. 19, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in…

4 hours ago

Pinealage: the app that turns strangers into meditation companions — in crowdfunding phase

This app will connect people with strangers to meditate together in the real world—an invitation…

4 hours ago

IMG Saxony-Anhalt: 2026 in Sight – Saxony-Anhalt Sets the Pace for Future Industries

Despite challenging framework conditions such as high energy prices, the international introduction of tariffs, and…

4 hours ago

Kirby Medical Center Partners with Switchboard, MD to Automate Patient Communication Workflows

ATLANTA, Dec. 19, 2025 /PRNewswire/ -- Switchboard, MD is proud to announce a new enterprise partnership with…

4 hours ago

SIERRA7 RECOGNIZED AS A 2026 ELEV8 GOVCON AWARD WINNER

MCLEAN, Va., Dec. 19, 2025 /PRNewswire/ -- Sierra7, a leader in government healthcare and technology solutions,…

4 hours ago

Medome Launch Heralds the End of Medical Misdiagnoses and Lost Lives

NEW YORK, Dec. 19, 2025 /PRNewswire/ -- Medome is the first AI technology for Personal Health…

4 hours ago